The calls are happening. The emails are piling up. And somewhere in the middle of back-to-back meetings, a Medicare Advantage quality leader is being asked, by their CMO, their CFO, their board, to explain what the Clover Health ruling means, what comes next, and what the plan is. The honest answer is that no one fully knows. And yet the expectation does not change.
I have spent significant time in the Medicare Advantage quality space. And what I know is this: the uncertainty we are navigating right now is not a temporary detour. When a federal court rules that CMS improperly applied 20 measures to star ratings calculations, when the agency is recalculating scores across contracts, when an appeal is expected, when Congress may need to get involved, and when the Star Year 2029 redesign is already running in parallel, you are not looking at a disruption. You are looking at a shift. And the leaders who treat it like the former are going to be caught flat-footed when the latter becomes undeniable.
So what does leadership actually look like in this moment? Not eventually. Right now. Here is my framework: three things every Medicare quality leader needs to be doing today.
One: Clear Your Mind First
This sounds simple. It is not.
There is a particular kind of mental clutter that comes with high-stakes ambiguity: the constant cycling through worst-case scenarios, the obsessive monitoring of every new legal development, the attempt to hold four possible futures in your head simultaneously and somehow act on all of them at once. It is exhausting. And it is the enemy of clear leadership.
Before you can lead your team through this, you have to be able to function without the noise. That is not the same as ignoring what is happening. It means developing the discipline to separate what you know from what you are afraid of, and making decisions from the former, not the latter. It means building the mental habit of stepping back from the chaos long enough to ask: what is actually true right now, and what is speculation?
Leaders who cannot do this personally cannot do it organizationally. The clutter you carry shows up in your communication, in your prioritization, in the signals your team picks up from your behavior even when you say nothing.
Clearing your mind is not a soft skill. In a moment like this one, it is a leadership prerequisite.
Two: Stabilize Before You Pivot
Here is one of the most common leadership mistakes I see in high-ambiguity environments: the impulse to redesign everything at once. To treat uncertainty as a mandate to reinvent. To interpret "things are changing" as "nothing that was working still works."
It does not hold up.
The Clover ruling has real implications: on how certain measures may be weighted, on the potential contraction of Part D quality metrics, on the future role of CAHPS and member experience measures. Those implications deserve serious attention in the specific areas where they land. But the answer is not to throw your entire quality infrastructure into question.
What was working before this news needs to keep working. Your HEDIS performance improvement programs, your member outreach strategies, your pharmacy engagement and medication adherence initiatives, these have always mattered, and they still matter, regardless of which of the four potential future versions of the Stars program ultimately emerges. The fundamentals of clinical quality are not in question. The court ruling did not change what good care looks like.
Stability, in this context, is a leadership decision. It means protecting your team from whiplash. It means being clear about what is being disrupted, the regulatory methodology, in certain specific areas, versus what is not. The pivot, when it comes, should be targeted and deliberate, applied only to the downstream impacts that are directly traceable to this specific development.
Trying to solve for every possible scenario under the umbrella of this case is not strategy. It is anxiety dressed up as action.
Hold the line on what works. Adjust where adjustment is actually warranted. That distinction is the job.
Three: Build Defensible Strategies, Not Perfect Ones
This is the piece that separates good leaders from great ones in uncertain environments.
A defensible strategy is not the same as a guaranteed strategy. It does not require you to predict the future correctly. What it requires is that your approach is substantive enough, rigorous enough, and well-reasoned enough that you can walk into any room, with your C-Suite, with your board, with your team, and explain not just what you decided, but why. And if the outcome does not go the way you intended, the rationale holds. The organization says: that made sense. We made a reasonable bet in a difficult environment. We will not hold you accountable for the uncertainty, only for how you led through it.
That is what leadership accountability actually looks like in ambiguous times. Not guaranteeing results you cannot guarantee. Demonstrating judgment that earns trust regardless of outcome.
To build defensible strategies right now, you need two things. The first is transparency: your team needs to understand what is happening. Not a sanitized version, not a confidence performance, but an honest accounting of what the ruling means, what remains unknown, and how you are thinking about it.
Transparency is not a vulnerability. It is what keeps your team from filling the information vacuum with fear.
The second is scenario literacy: the ability to model your organization's performance across multiple potential futures and make intelligent trade-offs. Not because you know which future is coming, but because you can articulate why your choices hold up across more than one of them.
The Deeper Truth: Dexterity Has Always Been the Job
For anyone who has been in the Medicare Advantage space for any length of time, this is a familiar feeling, even if the stakes feel higher than usual. This program has always required dexterity. The rules have always evolved. What was true even a few Star Years ago is not necessarily true today, and what is true today may not be true in 2029.
But I want to be honest about something: this moment feels different to me. Not just a policy evolution. Something closer to an actual structural shift: in how quality is defined, in what the regulatory framework can withstand legally, in what the relationship between CMS, Congress, and the industry is going to look like going forward. The Clover ruling did not just poke a hole in a methodology. It raised fundamental questions about statutory authority that may require legislative solutions. That is a different category of change.
The leaders who come out ahead are not the ones waiting for this to resolve. There is no "back to normal" on the horizon.
The ones who will lead most effectively are those who accept that, and start building organizations that do not need stability as a precondition for performance.
Clear mind. Stable team. Defensible strategy.
That is the job. Right now, it always has been.